Increased fibrin/fibrinogen degradation products without increase of plasmin-α2-plasmin inhibitor complex after hepatectomy for hepatocellular carcinoma
- 1 January 1990
- journal article
- research article
- Published by Elsevier in Thrombosis Research
- Vol. 57 (2) , 289-300
- https://doi.org/10.1016/0049-3848(90)90328-a
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Diagnostic efficacy of six plasma proteins in evaluating consumptive coagulopathies. Use of receiver operating characteristic curves to compare antithrombin III, plasminogen, alpha 2-plasmin inhibitor, fibronectin, prothrombin, and protein CArchives of internal medicine (1960), 1986
- Serum crosslinked fibrin (XDP) and fibrinogen/fibrin degradation products (FDP) in disorders associated with activation of the coagulation or fibrinolytic systemsBritish Journal of Haematology, 1985
- Plasmin‐a2‐antiplasmin complexes in bleeding disorders characterized by primary or secondary fibrinolysisBritish Journal of Haematology, 1984
- Determination of plasmin-α2-antiplasmin complex in plasma samples by means of a radioimmunoassayScandinavian Journal of Clinical and Laboratory Investigation, 1983
- Significance of plasma fibrinopeptide A and high molecular weight fibrinogen in patients with liver cirrhosisBritish Journal of Haematology, 1982
- Sequence of Fibrinogen Proteolysis and Platelet Release after Intrauterine Infusion of Hypertonic SalineJournal of Clinical Investigation, 1979
- Quantitation of the Reticuloendothelial System Clearance of Soluble FibrinBritish Journal of Haematology, 1977
- Measurement of Fibrinopeptide A in Human BloodJournal of Clinical Investigation, 1974
- Significance of intravascular coagulation and fibrinolysis in acute hepatic failureGut, 1974
- Intravascular Coagulation in Liver DiseaseAnnual Review of Medicine, 1974